Loki focuses on treating solid tumors and metastases through the activation and redirection of memory T-cells. Our patent AWAKE platform allows the targeting and elimination of a wide variety of difficult to treat cancers, including advanced pancreatic and ovarian cancers.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):